These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19579803)

  • 21. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of naftifine hydrochloride alcohol-free niosome gel.
    Barakat HS; Darwish IA; El-Khordagui LK; Khalafallah NM
    Drug Dev Ind Pharm; 2009 May; 35(5):631-7. PubMed ID: 18989805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles.
    Nounou MM; El-Khordagui LK; Khalafallah N
    Acta Pol Pharm; 2005; 62(5):369-79. PubMed ID: 16459486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
    Kalariya M; Padhi BK; Chougule M; Misra A
    Indian J Exp Biol; 2005 Mar; 43(3):233-40. PubMed ID: 15816409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
    Garg BJ; Garg NK; Beg S; Singh B; Katare OP
    J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.
    Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
    Int J Pharm; 2006 Sep; 322(1-2):60-6. PubMed ID: 16806755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis.
    Gupta M; Vyas SP
    Chem Phys Lipids; 2012 May; 165(4):454-61. PubMed ID: 22309657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes- and ethosomes-associated distamycins: a comparative study.
    Cortesi R; Romagnoli R; Drechsler M; Menegatti E; Zaid AN; Ravani L; Esposito E
    J Liposome Res; 2010 Dec; 20(4):277-85. PubMed ID: 19961302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.
    Guo F; Wang J; Ma M; Tan F; Li N
    J Mater Sci Mater Med; 2015 Apr; 26(4):175. PubMed ID: 25825320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
    Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug.
    Bodade SS; Shaikh KS; Kamble MS; Chaudhari PD
    Drug Deliv; 2013; 20(1):40-6. PubMed ID: 23311652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study.
    Zhang JP; Wei YH; Zhou Y; Li YQ; Wu XA
    Arch Pharm Res; 2012 Jan; 35(1):109-17. PubMed ID: 22297749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in topical formulation carriers of antifungal agents.
    Bseiso EA; Nasr M; Sammour O; Abd El Gawad NA
    Indian J Dermatol Venereol Leprol; 2015; 81(5):457-63. PubMed ID: 26261140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation.
    Verma P; Pathak K
    Nanomedicine; 2012 May; 8(4):489-96. PubMed ID: 21839053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistically optimised ethosomes for transdermal delivery of tolterodine tartrate.
    Prasanthi D; Lakshmi PK
    Pak J Pharm Sci; 2013 Nov; 26(6):1117-22. PubMed ID: 24191315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
    López-Pinto JM; González-Rodríguez ML; Rabasco AM
    Int J Pharm; 2005 Jul; 298(1):1-12. PubMed ID: 15896932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
    Abdelkader H; Ismail S; Kamal A; Alany RG
    Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection.
    Pandit J; Garg M; Jain NK
    J Liposome Res; 2014 Jun; 24(2):163-9. PubMed ID: 24479833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
    Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
    J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A topical dosage form of liposomal clofazimine: research and clinical implications.
    Patel VB; Misra AN; Marfatia YS
    Pharmazie; 1999 Jun; 54(6):448-51. PubMed ID: 10399190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.